Open access · CC-BY
via OpenAlex
Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery
Francesca Romana Buccellato, Marianna D’Anca, Chiara Fenoglio, Elio Angelo Scarpini, Daniela Galimberti
Antioxidants · 2021 · ▲ 179 citations
Abstract
Alzheimer's disease (AD) is a neurodegenerative disorder accounting for over 50% of all dementia patients and representing a leading cause of death worldwide for the global ageing population. The lack of effective treatments for overt AD urges the discovery of biomarkers for early diagnosis, i.e., in subjects with mild cognitive impairment (MCI) or prodromal AD. The brain is exposed to oxidative stress as levels of reactive oxygen species (ROS) are increased, whereas cellular antioxidant defenses are decreased. Increased ROS levels can damage cellular structures or molecules, leading to protein, lipid, DNA, or RNA oxidation. Oxidative damage is involved in the molecular mechanisms which link the accumulation of amyloid-β and neurofibrillary tangles, containing hyperphosphorylated tau, to microglia response. In this scenario, microglia are thought to play a crucial role not only in the early events of AD pathogenesis but also in the progression of the disease. This review will focus on oxidative damage products as possible peripheral biomarkers in AD and in the preclinical phases of the disease. Particular attention will be paid to biological fluids such as blood, CSF, urine, and saliva, and potential future use of molecules contained in such body fluids for early differential diagnosis and monitoring the disease course. We will also review the role of oxidative damage and microglia in the pathogenesis of AD and, more broadly, in neurodegeneration.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/antiox10091353
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Buccellato, F.R., D’Anca, M., Fenoglio, C., Scarpini, E.A., & Galimberti, D. (2021). Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery. <em>Antioxidants</em>. https://doi.org/10.3390/antiox10091353
Vancouver
Buccellato FR, D’Anca M, Fenoglio C, Scarpini EA, Galimberti D. Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery. Antioxidants. 2021. doi:10.3390/antiox10091353.
BibTeX
@article{francesca2021Roleof,
title = {Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery},
author = {Francesca Romana Buccellato and Marianna D’Anca and Chiara Fenoglio and Elio Angelo Scarpini and Daniela Galimberti},
journal = {Antioxidants},
year = {2021},
doi = {10.3390/antiox10091353},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Medicinski pregled 2012
Open access · OA
Mechanisms of neurodegeneration in Alzheimer’s disease
PubMed 2012
Preprint
The immunopathogenic role of reactive oxygen species in Alzheimer disease.
Nutrients 2019
Open access · CC-BY
Role of Resveratrol and Selenium on Oxidative Stress and Expression of Antioxidant and Anti-Aging Genes in Immortalized Lymphocytes from Alzheimer’s Disease Patients
Qatar Foundation Annual Research Conference (ARC) 2016
Citation only
Alpha-Synuclein Oligomers as a Biomarker Candidate for Parkinson's Disease and Disorders
BENTHAM SCIENCE PUBLISHERS eBooks 2017
Citation only
Retinal Neurodegeneration in Alzheimer’s Disease
International Journal of Molecular Sciences 2013
Open access · CC-BY